Selected research
Industry Research
Animal Blood Plasma Products and Derivatives Industry Research Report 2026
Market perspective
The global Animal Blood Plasma Products and Derivatives market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Animal Blood Plasma Products and Derivatives is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Animal Blood Plasma Products and Derivatives is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Animal Blood Plasma Products and Derivatives include Thermo Fisher Scientific, Sigma-Aldrich, Rocky Mountain Biologicals, Proliant, LAMPIRE Biological Laboratories, Lake Immunogenics, Kraeber & Co. GmbH, Bovogen Biologicals and Auckland BioSciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Animal Blood Plasma Products and Derivatives market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Animal Blood Plasma Products and Derivatives Market by Company
Thermo Fisher Scientific
Sigma-Aldrich
Rocky Mountain Biologicals
Proliant
LAMPIRE Biological Laboratories
Lake Immunogenics
Kraeber & Co. GmbH
Bovogen Biologicals
Auckland BioSciences
ANZCO Foods
Animal Blood Plasma Products and Derivatives Segment by Type
Serum Albumin
Fibrinogen
Fetal Bovine Serum
Immunoglobulin
Animal Blood Plasma Products and Derivatives Segment by Application
Pharmaceutical Industry
Diagnostic Industry
Sports Nutrition
Nutrition Supplements
Cell Culture Media
Food Industry
Cosmetic Industry
Pet Food Industry
Animal Blood Plasma Products and Derivatives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Blood Plasma Products and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Blood Plasma Products and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Blood Plasma Products and Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Animal Blood Plasma Products and Derivatives manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Animal Blood Plasma Products and Derivatives by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Animal Blood Plasma Products and Derivatives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Serum Albumin
- Fibrinogen
- Fetal Bovine Serum
- Immunoglobulin
Applications
- Pharmaceutical Industry
- Diagnostic Industry
- Sports Nutrition
- Nutrition Supplements
- Cell Culture Media
- Food Industry
- Cosmetic Industry
- Pet Food Industry
Companies covered
- Thermo Fisher Scientific
- Sigma-Aldrich
- Rocky Mountain Biologicals
- Proliant
- LAMPIRE Biological Laboratories
- Lake Immunogenics
- Kraeber & Co. GmbH
- Bovogen Biologicals
- Auckland BioSciences
- ANZCO Foods
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Animal Blood Plasma Products and Derivatives Market Size (2021-2032)
- 2.2.2 Global Animal Blood Plasma Products and Derivatives Sales (2021-2032)
- 2.2.3 Global Animal Blood Plasma Products and Derivatives Market Average Price (2021-2032)
- 2.3 Animal Blood Plasma Products and Derivatives by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Serum Albumin
- 2.3.3 Fibrinogen
- 2.3.4 Fetal Bovine Serum
- 2.3.5 Immunoglobulin
- 2.4 Animal Blood Plasma Products and Derivatives by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical Industry
- 2.4.3 Diagnostic Industry
- 2.4.4 Sports Nutrition
- 2.4.5 Nutrition Supplements
- 2.4.6 Cell Culture Media
- 2.4.7 Food Industry
- 2.4.8 Cosmetic Industry
- 2.4.9 Pet Food Industry
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Animal Blood Plasma Products and Derivatives Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Animal Blood Plasma Products and Derivatives Sales (tons) of Manufacturers (2021-2026)
- 3.3 Global Animal Blood Plasma Products and Derivatives Revenue of Manufacturers (2021-2026)
- 3.4 Global Animal Blood Plasma Products and Derivatives Average Price by Manufacturers (2021-2026)
- 3.5 Global Animal Blood Plasma Products and Derivatives Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Animal Blood Plasma Products and Derivatives, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Animal Blood Plasma Products and Derivatives, Product Type & Application
- 3.8 Global Manufacturers of Animal Blood Plasma Products and Derivatives, Established Date
- 3.9 Global Animal Blood Plasma Products and Derivatives Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Thermo Fisher Scientific
- 4.1.1 Thermo Fisher Scientific Company Information
- 4.1.2 Thermo Fisher Scientific Business Overview
- 4.1.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Portfolio
- 4.1.5 Thermo Fisher Scientific Recent Developments
- 4.2 Sigma-Aldrich
- 4.2.1 Sigma-Aldrich Company Information
- 4.2.2 Sigma-Aldrich Business Overview
- 4.2.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Portfolio
- 4.2.5 Sigma-Aldrich Recent Developments
- 4.3 Rocky Mountain Biologicals
- 4.3.1 Rocky Mountain Biologicals Company Information
- 4.3.2 Rocky Mountain Biologicals Business Overview
- 4.3.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
- 4.3.5 Rocky Mountain Biologicals Recent Developments
- 4.4 Proliant
- 4.4.1 Proliant Company Information
- 4.4.2 Proliant Business Overview
- 4.4.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Proliant Animal Blood Plasma Products and Derivatives Product Portfolio
- 4.4.5 Proliant Recent Developments
- 4.5 LAMPIRE Biological Laboratories
- 4.5.1 LAMPIRE Biological Laboratories Company Information
- 4.5.2 LAMPIRE Biological Laboratories Business Overview
- 4.5.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Portfolio
- 4.5.5 LAMPIRE Biological Laboratories Recent Developments
- 4.6 Lake Immunogenics
- 4.6.1 Lake Immunogenics Company Information
- 4.6.2 Lake Immunogenics Business Overview
- 4.6.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Portfolio
- 4.6.5 Lake Immunogenics Recent Developments
- 4.7 Kraeber & Co. GmbH
- 4.7.1 Kraeber & Co. GmbH Company Information
- 4.7.2 Kraeber & Co. GmbH Business Overview
- 4.7.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Portfolio
- 4.7.5 Kraeber & Co. GmbH Recent Developments
- 4.8 Bovogen Biologicals
- 4.8.1 Bovogen Biologicals Company Information
- 4.8.2 Bovogen Biologicals Business Overview
- 4.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
- 4.8.5 Bovogen Biologicals Recent Developments
- 4.9 Auckland BioSciences
- 4.9.1 Auckland BioSciences Company Information
- 4.9.2 Auckland BioSciences Business Overview
- 4.9.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Portfolio
- 4.9.5 Auckland BioSciences Recent Developments
- 4.10 ANZCO Foods
- 4.10.1 ANZCO Foods Company Information
- 4.10.2 ANZCO Foods Business Overview
- 4.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 ANZCO Foods Animal Blood Plasma Products and Derivatives Product Portfolio
- 4.10.5 ANZCO Foods Recent Developments
5 Global Animal Blood Plasma Products and Derivatives Market Scenario by Region
- 5.1 Global Animal Blood Plasma Products and Derivatives Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Animal Blood Plasma Products and Derivatives Sales by Region: 2021-2032
- 5.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Region: 2021-2026
- 5.2.2 Global Animal Blood Plasma Products and Derivatives Sales by Region: 2027-2032
- 5.3 Global Animal Blood Plasma Products and Derivatives Revenue by Region: 2021-2032
- 5.3.1 Global Animal Blood Plasma Products and Derivatives Revenue by Region: 2021-2026
- 5.3.2 Global Animal Blood Plasma Products and Derivatives Revenue by Region: 2027-2032
- 5.4 North America Animal Blood Plasma Products and Derivatives Market Facts & Figures by Country
- 5.4.1 North America Animal Blood Plasma Products and Derivatives Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Animal Blood Plasma Products and Derivatives Sales by Country (2021-2032)
- 5.4.3 North America Animal Blood Plasma Products and Derivatives Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Animal Blood Plasma Products and Derivatives Market Facts & Figures by Country
- 5.5.1 Europe Animal Blood Plasma Products and Derivatives Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Animal Blood Plasma Products and Derivatives Sales by Country (2021-2032)
- 5.5.3 Europe Animal Blood Plasma Products and Derivatives Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Animal Blood Plasma Products and Derivatives Market Facts & Figures by Country
- 5.6.1 Asia Pacific Animal Blood Plasma Products and Derivatives Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Animal Blood Plasma Products and Derivatives Market Facts & Figures by Country
- 5.7.1 South America Animal Blood Plasma Products and Derivatives Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Animal Blood Plasma Products and Derivatives Sales by Country (2021-2032)
- 5.7.3 South America Animal Blood Plasma Products and Derivatives Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Animal Blood Plasma Products and Derivatives Sales by Type (2021-2032)
- 6.1.1 Global Animal Blood Plasma Products and Derivatives Sales by Type (2021-2032) & (tons)
- 6.1.2 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2021-2032)
- 6.2 Global Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2032)
- 6.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2021-2032)
- 6.3 Global Animal Blood Plasma Products and Derivatives Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Animal Blood Plasma Products and Derivatives Sales by Application (2021-2032)
- 7.1.1 Global Animal Blood Plasma Products and Derivatives Sales by Application (2021-2032) & (tons)
- 7.1.2 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2021-2032)
- 7.2 Global Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2032)
- 7.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2021-2032)
- 7.3 Global Animal Blood Plasma Products and Derivatives Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Animal Blood Plasma Products and Derivatives Value Chain Analysis
- 8.1.1 Animal Blood Plasma Products and Derivatives Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Animal Blood Plasma Products and Derivatives Production Mode & Process
- 8.2 Animal Blood Plasma Products and Derivatives Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Animal Blood Plasma Products and Derivatives Distributors
- 8.2.3 Animal Blood Plasma Products and Derivatives Customers
9 Global Animal Blood Plasma Products and Derivatives Analyzing Market Dynamics
- 9.1 Animal Blood Plasma Products and Derivatives Industry Trends
- 9.2 Animal Blood Plasma Products and Derivatives Industry Drivers
- 9.3 Animal Blood Plasma Products and Derivatives Industry Opportunities and Challenges
- 9.4 Animal Blood Plasma Products and Derivatives Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst